BioSpace News Archive

Business

Life Sciences Pioneer Stanley Lapidus Joins Atlas Genetics Board of Directors

Lapidus has more than 30 years’ experience in the medical diagnostics industry as a founder, CEO and board member at companies that have dramatically impacted the diagnostics landscape, including his founding of EXACT Sciences Corp.

January 5, 2018
·
3 min read
Policy

Spruce Biosciences Receives EMA Orphan Drug Designation for SPR001 for the Treatment of Congenital Adrenal Hyperplasia

Earlier this month, Spruce also received orphan drug designation for SPR001 from the FDA.

January 5, 2018
·
1 min read
FDA

FDA Approves Expanded Use of Amgen’s Xgeva

The approval is based on data from the pivotal Phase 3 ‘482 study, the largest international multiple myeloma clinical trial ever conducted, which enrolled 1,718 patients.

January 5, 2018
·
18 min read
Drug Development

Momenta Pharmaceuticals Reports Positive Top-Line Phase I Data Showing Proof of Mechanism for M281, an Anti-FcRn Monoclonal Antibody, in Healthy Volunteers

M281 data shows safety and tolerability with no serious adverse events.

January 5, 2018
·
5 min read
Biotech Beach

Peregrine Pharmaceuticals Announces Name Change to Avid Bioservices as Part of Transition to Dedicated Contract Development and Manufacturing Organization (CDMO)

The name and ticker symbol changes will both be effective as of market open on Monday, January 8, 2018.

January 5, 2018
·
3 min read
Business

Retrophin and Censa Pharmaceuticals Enter Into Strategic Collaboration to Advance CNSA-001 for the Treatment of Phenylketonuria (PKU)

Retrophin obtains exclusive option to purchase Censa post proof-of-concept study.

January 5, 2018
·
7 min read
Biotech Bay

HSE-AG Introduces Modular, Automated qPCR TubeSealer

HSE-AG announced the introduction of the TubeSealer today - an integratable module that automatically, safely, and reliably seals qPCR tubes and plates.

January 5, 2018
·
2 min read
Business

Global Genomics Group and Datavant Announce Strategic Partnership to Improve Design and Interpretation of Clinical Trials

Through this partnership, Datavant and G3 will work together to increase the odds of success and pace of drug development through data-driven approaches.

January 5, 2018
·
3 min read
RTI Surgical Outlines 2018 Guidance and Long-Term Goals

RTI Surgical, a global surgical implant company, today outlined its 2018 guidance and long-term financial goals.

January 5, 2018
·
3 min read
Deals

Owens & Minor Announces Updates on Pending Acquisition of Halyard Health’s S&IP Business

As part of the integration plan for the S&IP business, Owens & Minor anticipates it will organize into two strategic business units (SBUs): Global Solutions and Global Products.

January 5, 2018
·
4 min read